Price
No data yet.
Social Signal Score
Revenue
$1.31M+5170.08%Company Profile
- CEO
- Graydon Bensler
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 33
- Beta
- -0.25
- Country
- US
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- -1.94
Financials
Revenue
$1.31M+5170.1%Net Income
$-2.94MEBITDA
$-3.51MFree Cash Flow
$-1.96MEPS (diluted)
$-6.00Shares Outstanding (diluted)
487.6K-97.2%Operating Expenses
$888.2KCash & Debt
$18.79MReturn of Capital
$0.00Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $590.1K | $-7.71M | $-3787.40 |
| 2024 | $2.47M | $-6.25M | $-65923.20 |
| 2023 | $0.00 | $-4.30M | $-477946.33 |
| 2022 | $766.3K | $-1.80M | $-158.40 |
| 2021 | $827.00 | $-784.7K | $-887.71 |
| 2020 | $0.00 | $-222.9K | $-19.79 |
Valuation
ELABhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
80-20.00%Social Signal Score
Mentions (7)
- Newsglobenewswire.com·5d ago·Negative
PMGC Holdings (Nasdaq: ELAB) Announces Completion of $100 Million SPAC IPO, Launching NorthStrive Acquisition Corp. I (Nasdaq: NSAI) as First in Planned SPAC Sponsorship Franchise to Expand M&A Strategy PMGC's first sponsored SPAC adds a public-market acquisition vehicle to the holding company, targeting aerospace and defense, industrial technology, and critical supply chain manufacturers Sponsor position of approximately 2.7 million shares, or roughly 21.4% of NorthStrive Acquisition Corp I.'s …
View source ↗ - Newsglobenewswire.com·18d ago·Positive
PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdin
View source ↗ - Newsglobenewswire.com·41d ago·Neutral
PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfolio PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Acr
View source ↗ - Newsglobenewswire.com·42d ago·Negative
PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22 and EL-32, Targeting Microgravity-Induced Muscle Loss PMGC Holdings Announces Term Sheet with Orbit2Orbit for NorthStrive Biosciences to Launch a Spaceflight Study of Its Myostatin and Activin A Assets, EL-22
View source ↗ - Newsglobenewswire.com·46d ago·Neutral
NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight
View source ↗ - Newsglobenewswire.com·47d ago·Neutral
PMGC Holdings Inc. Announces Anticipated Reverse Stock Split NEWPORT BEACH, Calif., Aug. 19, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”) today announced that it will effect a 1-for-10 reverse stock split (the “Split”) of its issued and outstanding and authorized common stock, par value $0.0001 per share (“Common Stock”), effective at 12:00 am, Eastern time, on August 21, 2026.
View source ↗ - Newsglobenewswire.com·53d ago·Neutral
PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q2 2026 Results and Files Form 10-Q; Total Assets Reach $36.6 Million, Up 184% from Year-End 2025 and 290% Year-over-Year, as Quarterly Revenue Nearly Doubles Sequentially PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q2 2026 Results and Files Form 10-Q; Total Assets Reach $36.6 Million, Up 184% from Year-End 2025 and 290% Year-o
View source ↗
Insider trading
Open-market buys and sells by ELAB officers and directors.
- Bought
- —
- Sold
- $5.7m
0 trades
5 trades
- Gransee David Hsold
- Karp Douglas Msold
- Patterson Mark Rsold
- Gransee David Hsold
- Gransee David Hsold
71 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in ELAB.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.